Skip navigation

Calls to Action

Robert Ring

Autism Tops Reuters List of European Innovative Medicine Programs

September 15, 2014

(Sept. 15, 2014) Thomson Reuters Research Analytics has rated EU-AIMS – the autism research program of the European Innovative Medicines Initiative (IMI) – as the initiative’s best-performing area. The rating is based on the number and quality of scientific papers coming out of the program.

Autism Speaks' Rob Ring to Serve on Interagency Autism Coordinating Committee

Newly appointed to the IACC, Autism Speaks' chief science officer redoubles pledge to put science to work for families
July 02, 2014

Today, the U.S. Department of Health & Human Services announced the appointment of Autism Speaks Chief Science Officer Rob Ring as a new public member of the Interagency Autism Coordinating Committee (IACC). The committee advises the government on federally funded autism research and related activities. It also provides a forum for public input on these issues.

Autism Speaks Names 2014 Meixner Postdoctoral Fellows in Translational Research

Supporting early careers in autism research while advancing diagnosis, treatment and support for those living with autism
June 26, 2014


Autism Speaks is pleased to announce its 2014 class of Meixner Postdoctoral Fellows in Translational Research. The fellowship program invests in rising talent within the autism research community and is supported by a generous gift by the estate of the late Charles Meixner.

Lifetime Costs of Autism Average $1.4 Million to $2.4 Million

Landmark study, funded by Autism Speaks, provides crucial information for public policy and service planning across the lifespan
June 09, 2014

 

Research funded by Autism Speaks has provided the most comprehensive and current estimate of autism’s costs to individuals, families and society:

Study Provides ‘Formula’ for Predicting Effects of Autism-linked Genes

Research co-funded by Autism Speaks promises to improve early identification of autism and identify biological targets for treatment
May 25, 2014

 

Researchers funded by Autism Speaks have helped devise a “genetic formula” that promises to improve the accuracy of early screening for autism and speed the identification of biological targets for future treatments.